Real-world experience with pro re nata dosing of intravitreal dexamethasone implant for eyes with refractory diabetic macular edema

2020/04/08 by Pukhraj Rishi, Rishi, Pukhraj, Ekta Rishi +7
Medicine · #610 Medical sciences #Glaucoma and retinal disorders #Medicine #Ozurdex® #Retinal Diseases and Treatments #Retinal Imaging and Analysis #dexamethasone #diabetes mellitus #intravitreal injection #macular edema #recalcitrant diabetic macular edema

paper · doi:10.3205/oc000148

openalex publication_date 2020/04/08 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/19

Abstract

Intravitreal dexamethasone implant is effective in treatment of refractory DME. However, its therapeutic effect lasts for about 4 months.

Related

• Intravitreal steroids for macular edema in diabetes
• Early versus Late Switch to an Intravitreal Dexamethasone Implant after Failed Anti-VEGF Therapy for Diabetic Macular Edema: A Systematic Review and Meta-Analysis
• Diabetic Retinopathy: A Position Statement by the American Diabetes Association
• Patient Experience Survey Of Anti-VEGF Treatment for Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
• A Survey of the Management of Diabetic Macular Oedema in Sub-Saharan Africa